Industry Strength Score
56/100
Composite price performance score based on 3, 6, and 12-month returns, with more weight on recent trends.
HYPERLIQUID STRATEGIES (PURR) Stock Price & Overview
NASDAQ:PURR • US44916Y1064
Current stock price
6.27 USD
+0.25 (+4.15%)
At close:
6.3 USD
+0.03 (+0.48%)
After Hours:
The current stock price of PURR is 6.27 USD. Today PURR is up by 4.15%. In the past month the price increased by 26.67%.
PURR Key Statistics
1-Month Range4.505 - 6.88
Current PURR stock price positioned within its 1-month range.
- Market Cap
- 777.292M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- N/A
- Dividend Yield
- N/A
PURR Stock Performance
Today
+4.15%
1 Week
+4.50%
1 Month
+26.67%
3 Months
+38.11%
Longer-term
6 Months N/A
1 Year N/A
2 Years N/A
3 Years N/A
5 Years N/A
10 Years N/A
PURR Stock Chart
PURR Technical Analysis
ChartMill assigns a technical rating of 7 / 10 to PURR.
Chartmill TA Rating
Chartmill Setup Rating
PURR Earnings
Next Earnings DateN/A
Last Earnings DateFeb 10, 2026
PURR Forecast & Estimates
8 analysts have analysed PURR and the average price target is 7.37 USD. This implies a price increase of 17.54% is expected in the next year compared to the current price of 6.27.
Analysts
Analysts82.5
Price Target7.37 (17.54%)
EPS Next YN/A
Revenue Next YearN/A
PURR Financial Highlights
Income Statements
Revenue(TTM)N/A
Net Income(TTM)N/A
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
Chartmill High Growth Momentum
EPS Q2Q%N/A
Sales Q2Q%N/A
EPS 1Y (TTM)N/A
Revenue 1Y (TTM)N/A
PURR Ownership
Ownership
Inst Owners23%
Shares123.97M
Float118.41M
Ins Owners0.98%
Short Float %7.87%
Short Ratio1.85
PURR Industry Overview
PURR operates in the Biotechnology sub-industry within the Health Care sector. This group contains 416 stocks and is scored by ChartMill on both price strength and growth momentum.
Industry Growth Score
13/100
Composite growth score based on earnings growth, revenue growth, and profitability across the sub-industry.
Relative Performance
Each rank shows how many other sub-industries were outperformed over that timeframe.
1 Month Rank
26%
Outperformed 26% of sub-industries
3 Month Rank
50%
Outperformed 50% of sub-industries
6 Month Rank
32%
Outperformed 32% of sub-industries
Industry Fundamentals & Breadth
- Members
- 416
- New Highs
- 5.1%
- New Lows
- 4.6%
- Average ROE
- 48.5%
- Average Profit Margin
- 20.5%
- Average Operating Margin
- 33.6%
- Average P/E
- 22.9
- Average Fwd P/E
- 18.2
- Average Debt/Equity
- 2.2
PURR Competitors/Peers
The largest stocks on the US markets in the "Biotechnology" sub-industry
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 12.59 | 373.774B | ||
| AMGN | AMGEN INC | 13.88 | 186.868B | ||
| GILD | GILEAD SCIENCES INC | 14.89 | 162.401B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 21.77 | 108.708B | ||
| REGN | REGENERON PHARMACEUTICALS | 12.72 | 74.75B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | 27.54 | 41.295B | ||
| INSM | INSMED INC | N/A | 29.427B | ||
| NTRA | NATERA INC | N/A | 29.219B | ||
| RVMD | REVOLUTION MEDICINES INC | N/A | 28.56B | ||
| BIIB | BIOGEN INC | 11.44 | 27.779B | ||
| UTHR | UNITED THERAPEUTICS CORP | 19.52 | 25.042B | ||
| INCY | INCYTE CORP | 10.61 | 18.96B | ||
| MRNA | MODERNA INC | N/A | 18.219B |
Related stock screener links
View all stocks in the Biotechnology Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About PURR
Company Profile
Hyperliquid Strategies, Inc. is a holding and operating company, which engages in the business of crypto asset management. The company is headquartered in New York City, New York. The company went IPO on 2025-12-03. The firm is focused on accumulating HYPE, the native token of Hyperliquid, a high-performance blockchain custom-built to house all of finance. The Company’s subsidiary is Sonnet BioTherapeutics Holdings, Inc., which is an oncology-focused biotechnology company with a proprietary platform for innovating biologic drugs of single or bifunctional action.
Company Info
IPO: 2025-12-03
HYPERLIQUID STRATEGIES
477 Madison Avenue, 22nd Floor
New York City NEW YORK US
Employees: 0
Phone: 13026587581
HYPERLIQUID STRATEGIES / PURR FAQ
What does PURR do?
Hyperliquid Strategies, Inc. is a holding and operating company, which engages in the business of crypto asset management. The company is headquartered in New York City, New York. The company went IPO on 2025-12-03. The firm is focused on accumulating HYPE, the native token of Hyperliquid, a high-performance blockchain custom-built to house all of finance. The Company’s subsidiary is Sonnet BioTherapeutics Holdings, Inc., which is an oncology-focused biotechnology company with a proprietary platform for innovating biologic drugs of single or bifunctional action.
What is the current price of PURR stock?
The current stock price of PURR is 6.27 USD. The price increased by 4.15% in the last trading session.
What is the dividend status of HYPERLIQUID STRATEGIES?
PURR does not pay a dividend.
What is the ChartMill rating of HYPERLIQUID STRATEGIES stock?
PURR has a ChartMill Technical rating of 7 out of 10.You can find more details on the Technical Analysis and Fundamental Analysis tabs.
Which stock exchange lists PURR stock?
PURR stock is listed on the Nasdaq exchange.
What sector and industry does HYPERLIQUID STRATEGIES belong to?
HYPERLIQUID STRATEGIES (PURR) operates in the Health Care sector and the Biotechnology industry.
What is HYPERLIQUID STRATEGIES worth?
HYPERLIQUID STRATEGIES (PURR) has a market capitalization of 777.29M USD. This makes PURR a Small Cap stock.